Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Skoog

Showing results (161-170 of 215) with videos related to

Pageof 22
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 1, 1987
Estrogen receptor levels and survival of breast cancer patients. A study on patients participating in randomized trials of adjuvant therapyL Skoog, S Humla, M Axelsson, et al.
Scandinavian Journal of Haematology|September 1, 1983
A study of the reproducibility of the diagnostic criteria for acute leukaemiaA Ost, B Lagerlöf, C Sundström, et al.
Acta Oncologica (Stockholm, Sweden)|February 9, 2006
Expression of sex steroid receptor subtypes in normal and malignant breast tissue - a pilot study in postmenopausal womenL Löfgren, L Sahlin, B Von Schoultz, et al.
Acta Oncologica (Stockholm, Sweden)|July 31, 1999
Proliferating fraction during neoadjuvant chemotherapy of primary breast cancer in relation to objective local response and relapse-free survivalA M Billgren, L E Rutqvist, E Tani, et al.
Diagnostic Cytopathology|October 20, 1999
Fine-needle aspiration cytology of renal-cell adenocarcinoma metastatic to the breast: A report of three casesD C Chhieng, J M Cohen, J Waisman, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Lack of correlation between anxiety parameters and oestrogen receptor status in early breast cancerS Rosenqvist, G Berglund, C Bolund, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2009
Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancerB K Linderholm, H Hellborg, U Johansson, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Non-palpable invasive breast carcinomas from the Stockholm screening projectA von Rosen, J Frisell, U Glas, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1989
Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancerO Stål, S Wingren, J Carstensen, et al.
British Journal of Cancer|January 1, 1997
Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer familiesM Zelada-Hedman, A L Børresen-Dale, A Claro, et al.
Pageof 22

Showing results (161-170 of 215) with videos related to

Sort By:
Pageof 22
Acta Oncologica (Stockholm, Sweden)|January 1, 1987
Estrogen receptor levels and survival of breast cancer patients. A study on patients participating in randomized trials of adjuvant therapyL Skoog, S Humla, M Axelsson, et al.
Scandinavian Journal of Haematology|September 1, 1983
A study of the reproducibility of the diagnostic criteria for acute leukaemiaA Ost, B Lagerlöf, C Sundström, et al.
Acta Oncologica (Stockholm, Sweden)|February 9, 2006
Expression of sex steroid receptor subtypes in normal and malignant breast tissue - a pilot study in postmenopausal womenL Löfgren, L Sahlin, B Von Schoultz, et al.
Acta Oncologica (Stockholm, Sweden)|July 31, 1999
Proliferating fraction during neoadjuvant chemotherapy of primary breast cancer in relation to objective local response and relapse-free survivalA M Billgren, L E Rutqvist, E Tani, et al.
Diagnostic Cytopathology|October 20, 1999
Fine-needle aspiration cytology of renal-cell adenocarcinoma metastatic to the breast: A report of three casesD C Chhieng, J M Cohen, J Waisman, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Lack of correlation between anxiety parameters and oestrogen receptor status in early breast cancerS Rosenqvist, G Berglund, C Bolund, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2009
Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancerB K Linderholm, H Hellborg, U Johansson, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Non-palpable invasive breast carcinomas from the Stockholm screening projectA von Rosen, J Frisell, U Glas, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1989
Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancerO Stål, S Wingren, J Carstensen, et al.
British Journal of Cancer|January 1, 1997
Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer familiesM Zelada-Hedman, A L Børresen-Dale, A Claro, et al.
Pageof 22